Metagenomi, Inc. Common Stock
MGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 16.8% | 160.2% | 6,978.2% | – |
| Gross Profit | $0 | -$0 | $0 | -$0 |
| % Margin | 100% | -110.9% | 89.9% | -59.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -159.7% | -166% | -227.9% | -8,540.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -149.3% | -152.5% | -253.4% | -8,823.9% |
| EPS Diluted | -2.09 | -1.82 | -1.16 | -3.62 |
| % Growth | -14.8% | -56.9% | 68% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |